Aontas Advisory
AboutServicesSectorsCase StudiesInsightsContactBook a call
— Case · Oil & Gas

Boutique Oilfield Chemicals Operator Triples Annual Revenue

SAR 25m+New oilfield-chemicals revenue secured in a single year
Led by Dr. AymanLed by Brian O'HalloranBespoke Chemistry & R&D Commercialisation

A boutique Saudi oilfield-chemicals operator had spent five years selling commodity formulations into a saturated mid-tier of the Kingdom's upstream supply chain. Margins were thinning, and two of its three flagship products had been re-tendered against lower-cost Asian imports in the previous twelve months. The founders wanted to climb out of price competition and into a defensible technical position — without acquiring a multinational R&D function they could not afford.

The challenge

The operator had the field credibility to be heard by senior production engineers at major Saudi operators, but no proprietary chemistry to put in front of them. Every conversation eventually devolved into a price comparison against an international major. The firm had attempted in-house formulation work twice and abandoned both efforts — neither yielded a stable product, and neither had been independently validated to the standard a tier-one buyer would accept.

The opening was clear but narrow. A category of high-temperature, high-salinity production chemistry was being re-specified across several Eastern Province fields, and incumbent suppliers were over-engineered against the new performance window. A genuinely fit-for-field formulation, validated by a credible name, could move quickly.

Approach

Aontas paired the engagement across two consultants. Dr. Ayman Al-Nakhli, formerly of the Aramco Research Centre and CEO of SMART Chem, led the chemistry track. Brian O'Halloran led commercial positioning and account access.

  • Scoped a co-development arrangement between the operator and SMART Chem covering two production-chemistry product families
  • Reformulated the lead product against the new high-temperature, high-salinity performance envelope, drawing on Dr. Al-Nakhli's patent portfolio and ARC-era field data
  • Validated the formulation through controlled core-flood and compatibility testing, producing a technical dossier suitable for tier-one operator review
  • Repositioned the operator's commercial pitch around the co-developed product, with Dr. Al-Nakhli named as technical principal and Brian leading buyer engagement
  • Sequenced introductions to production-chemistry category leads inside two major Saudi operators over a four-month window

The collaboration did not behave like a traditional R&D outsourcing arrangement. Dr. Al-Nakhli's involvement was named in the technical dossier and present in the room for senior buyer reviews — converting a small operator's pitch into a conversation that buyers were willing to have at the principal-engineer level. Brian's account work then turned that technical credibility into trial volumes inside two fields.

Outcome

Inside the first year of the partnership, the operator booked SAR 25m+ in net new revenue from the co-developed product line — broadly tripling the prior year's total revenue. Two of the trial deployments were converted into framework supply positions, and the operator was added to the qualified vendor list of a third major Saudi producer.

SAR 25m+Net new revenue in twelve months from a single co-developed product line

Cumulative commercialised value across Dr. Al-Nakhli's broader portfolio now exceeds USD 500m, anchored by 50+ patents and recognised at the World Oil Awards. For this operator, the partnership has shifted the business from competing on price to defending a technical position.

"We stopped being the cheap option. Having Dr. Al-Nakhli in the room changed how the buyer treated the conversation — and Brian made sure the conversation actually happened. A year later, we are tendering on chemistry, not on margin."

Founder and Chief Executive, Saudi oilfield-chemicals operator